CM
KRON

CM Management’s Kronos Bio KRON Stock Holding History

CM Management’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-200,000
Closed -$200K – 62
2024
Q3 		$200K Buy
200,000
+65,000
+48% +$72K 0.16% 62
2024
Q2 		$167K Sell
135,000
-115,000
-46% -$117K 0.15% 62
2024
Q1 		$325K Hold
250,000
– – 0.27% 62
2023
Q4 		$313K Hold
250,000
– – 0.25% 65
2023
Q3 		$325K Hold
250,000
– – 0.34% 54
2023
Q2 		$430K Buy
250,000
+70,000
+39% +$111K 0.42% 56
2023
Q1 		$263K Buy
180,000
+150,000
+500% +$288K 0.31% 56
2022
Q4 		$49K Buy
+30,000
New +$69.1K 0.06% 72

Other funds holding KRON

VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CM Management's KRON Position: Q4 2024 in Review

CM Management sold out of Kronos Bio (KRON) in Q4 2024, closing a stake of 200,000 shares — an estimated $200K sold.

CM Management first reported a position in KRON in Q4 2022 and held it in 8 quarters. The position peaked at $430K in Q2 2023. 56 funds tracked by Wall St. Rank hold KRON as of Q4 2024.

  • CM Management reported no remaining Kronos Bio position as of Q4 2024 after selling out during the quarter.
  • CM Management sold 200,000 Kronos Bio shares in Q4 2024, an estimated $200K.
  • CM Management first reported a position in Kronos Bio in Q4 2022 and held it in 8 quarters.
  • CM Management's Kronos Bio position peaked at $430K in Q2 2023.
  • 56 funds tracked by Wall St. Rank held Kronos Bio as of Q4 2024.

Based on CM Management's 13F filing for Q4 2024, filed 7 Feb 2025.